BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28476831)

  • 1. DDR2 Expression Is Associated with a High Frequency of Peritoneal Dissemination and Poor Prognosis in Colorectal Cancer.
    Sasaki S; Ueda M; Iguchi T; Kaneko M; Nakayama H; Watanabe T; Sakamoto A; Mimori K
    Anticancer Res; 2017 May; 37(5):2587-2591. PubMed ID: 28476831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination.
    Kurashige J; Hasegawa T; Niida A; Sugimachi K; Deng N; Mima K; Uchi R; Sawada G; Takahashi Y; Eguchi H; Inomata M; Kitano S; Fukagawa T; Sasako M; Sasaki H; Sasaki S; Mori M; Yanagihara K; Baba H; Miyano S; Tan P; Mimori K
    Sci Rep; 2016 Mar; 6():22371. PubMed ID: 26934957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DDR2 overexpression in oral squamous cell carcinoma is associated to lymph node metastasis.
    Velmurugan BK; Chang WH; Chung CM; Yeh CM; Lee CH; Yeh KT; Lin SH
    Cancer Biomark; 2018; 22(4):747-753. PubMed ID: 29945346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
    Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDR2 and IFITM1 Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas.
    Li D; Yang Z; Liu Z; Zou Q; Yuan Y
    Pathol Oncol Res; 2019 Jan; 25(1):157-167. PubMed ID: 29043607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special issue "The advance of solid tumor research in China": Discoidin domain receptor 2 promotes colorectal cancer metastasis by regulating epithelial mesenchymal transition via activating AKT signaling.
    Xu X; Duan X; Wang S; Zhang Y; Gao Y; Xu X; Yeerkenbieke G; Zhou J; Li J
    Int J Cancer; 2023 Jan; 152(1):51-65. PubMed ID: 35904852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer.
    Wei JL; Fu ZX; Fang M; Guo JB; Zhao QN; Lu WD; Zhou QY
    Oncol Rep; 2015 Mar; 33(3):1349-57. PubMed ID: 25572852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of Rab1A and its prognostic significance in human colorectal cancer.
    Wang ZK; Cheng ZW; Chen SJ; Zhu XG; Gu YP; Yang XD; Sun L; Liu WT; Zhang YJ; Yuan JF; Tian KJ; Yao YZ; He SB
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4509-4517. PubMed ID: 30058685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer.
    de Cuba EM; de Hingh IH; Sluiter NR; Kwakman R; Coupé VM; Beliën JA; Verwaal VJ; Meijerink WJ; Delis-van Diemen PM; Bonjer HJ; Meijer GA; Te Velde EA
    Ann Surg Oncol; 2016 May; 23(5):1601-8. PubMed ID: 26727921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.
    Goi T; Kurebayashi H; Ueda Y; Naruse T; Nakazawa T; Koneri K; Hirono Y; Katayama K; Yamaguchi A
    Oncotarget; 2015 Oct; 6(31):31758-66. PubMed ID: 26372733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
    Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
    Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer.
    Yang B; Cao L; Liu J; Xu Y; Milne G; Chan W; Heys SD; McCaig CD; Pu J
    Cancer; 2015 May; 121(10):1570-80. PubMed ID: 25603912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis.
    Astrosini C; Roeefzaad C; Dai YY; Dieckgraefe BK; Jöns T; Kemmner W
    Int J Cancer; 2008 Jul; 123(2):409-413. PubMed ID: 18452172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of growth factor receptor-bound protein 14 predicts poor prognosis for colorectal cancer patients.
    Yang P; Wei J; Li W; He F; Zeng S; Zhang T; Sun Z; Cao J
    Biotechnol Lett; 2016 Jun; 38(6):1043-7. PubMed ID: 26965150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.
    Zeng J; Tang ZH; Liu S; Guo SS
    World J Gastroenterol; 2017 Mar; 23(10):1780-1786. PubMed ID: 28348483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of G protein-coupled receptor 31 as a poor prognosticator in human colorectal cancer.
    Rong YM; Huang XM; Fan DJ; Lin XT; Zhang F; Hu JC; Tan YX; Chen X; Zou YF; Lan P
    World J Gastroenterol; 2018 Nov; 24(41):4679-4690. PubMed ID: 30416315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.
    Takahashi Y; Iwaya T; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Takano Y; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2014 Jan; 21(1):205-12. PubMed ID: 24046120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.
    Nakazawa T; Goi T; Hirono Y; Yamaguchi A
    Ann Surg Oncol; 2015 May; 22(5):1496-503. PubMed ID: 25331005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
    Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
    Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.